Pauwels joins NPS Pharmaceuticals

Tuesday, September 27, 2011 01:08 PM

NPS Pharmaceuticals has named Eric Pauwels as senior vice president and chief commercial officer.

Pauwels brings more than 25 years of global commercial experience to NPS Pharmaceuticals. He was most recently the chief marketing officer at Accuray, a radiation oncology company.

“Eric’s global experience commercializing drugs for rare diseases makes him ideally suited to lead our commercial team,” said Francois Nader, MD, president and chief executive officer of NPS Pharmaceuticals.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs